Cengild Medical Berhad (KLSE:CENGILD)

Cengild Medical Berhad Ratios and Metrics

Market cap in millions MYR. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 22, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	187	192	262	329	328	-
Market Cap Growth	-19.64%	-26.98%	-20.25%	0.45%	-	-
Enterprise Value	167	138	188	255	331	-
Last Close Price	0.23	0.23	0.30	0.37	0.37	-
PE Ratio	15.68	17.33	23.68	24.76	34.88	-
Forward PE	-	23.00	23.00	23.00	24.24	-
PS Ratio	2.45	2.40	3.93	4.68	5.08	-
PB Ratio	1.64	1.67	2.36	3.10	3.52	-
P/TBV Ratio	1.64	1.67	2.36	3.10	3.52	-
P/FCF Ratio	-	-	-	27.92	21.98	-
P/OCF Ratio	10.32	11.91	20.28	23.65	21.37	-
PEG Ratio	-	0.64	0.64	0.64	0.67	-
EV/Sales Ratio	2.18	1.72	2.82	3.62	5.14	-
EV/EBITDA Ratio	8.86	7.10	11.94	15.59	22.72	-
EV/EBIT Ratio	13.42	9.60	14.24	17.60	28.61	-
EV/FCF Ratio	-4.10	-	-	21.60	22.21	-
Debt / Equity Ratio	0.52	0.42	0.07	0.14	0.17	1.76
Debt / EBITDA Ratio	3.31	2.28	0.47	0.85	1.01	1.25
Debt / FCF Ratio	-	-	-	1.27	1.09	1.92
Asset Turnover	0.46	0.51	0.51	0.56	0.78	1.36
Inventory Turnover	20.18	22.93	23.09	31.23	36.62	42.83
Quick Ratio	3.63	4.78	6.59	9.17	7.91	1.06
Current Ratio	3.71	4.91	6.73	9.32	8.04	1.16
Return on Equity (ROE)	10.55%	12.02%	11.01%	13.35%	17.60%	84.90%
Return on Assets (ROA)	4.37%	5.72%	6.25%	7.19%	8.74%	19.43%
Return on Invested Capital (ROIC)	10.46%	20.41%	37.02%	50.17%	33.82%	33.92%
Return on Capital Employed (ROCE)	6.80%	8.90%	11.20%	12.00%	10.70%	41.30%
Earnings Yield	5.32%	5.77%	4.22%	4.04%	2.87%	-
FCF Yield	-21.68%	-11.06%	-1.07%	3.58%	4.55%	-
Dividend Yield	4.31%	4.29%	2.47%	2.02%	1.01%	-
Payout Ratio	50.10%	73.07%	55.64%	45.60%	-	72.81%
Buyback Yield / Dilution	0.04%	0.11%	-1.00%	-27.94%	-7.56%	-4700.00%
Total Shareholder Return	4.25%	4.40%	1.48%	-25.92%	-6.55%	-4700.00%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.